These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinase. Ruppert C; Mahavadi P; Wygrecka M; Weaver TE; Magdolen V; Idell S; Preissner KT; Seeger W; Günther A; Markart P Thromb Haemost; 2008 Dec; 100(6):1185-92. PubMed ID: 19132247 [TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase. Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477 [TBL] [Abstract][Full Text] [Related]
11. Soluble expression of a strong thrombolytic pro-urokinase mutant in Escherichia coli. Lin J; Yang X; Deng R; Yu B; Lai H; Sun W; Wu W Protein Expr Purif; 2006 Jul; 48(1):69-73. PubMed ID: 16503165 [TBL] [Abstract][Full Text] [Related]
12. [Biological function of fusion protein ATF-PAI2CD]. Wang X; Li P; Zhang YQ; Hou M; Sun XH; Tan L; Zhu YS Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):624-8. PubMed ID: 12883632 [TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of a recombinant chimeric plasminogen activator consisting of a fibrin peptide and a low molecular mass single-chain urokinase. Jiao J; Yu M; Ru B Biochimie; 2001; 83(11-12):1049-55. PubMed ID: 11879733 [TBL] [Abstract][Full Text] [Related]
14. An efficient system for production of recombinant urokinase-type plasminogen activator. Tang W; Sun ZY; Pannell R; Gurewich V; Liu JN Protein Expr Purif; 1997 Dec; 11(3):279-83. PubMed ID: 9425632 [TBL] [Abstract][Full Text] [Related]
15. In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides. Chen W; Li Y; Chen P; Wu M; Wang L; Zhang H; Wang L J Thromb Thrombolysis; 2016 Jul; 42(1):118-26. PubMed ID: 26814674 [TBL] [Abstract][Full Text] [Related]
16. Expression of a fibrinolytically active human pro-urokinase fusion protein in Escherichia coli. Hua Z; Jie L; Zhu D Biochem Mol Biol Int; 1994 Aug; 33(6):1215-20. PubMed ID: 7804148 [TBL] [Abstract][Full Text] [Related]
18. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells. Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589 [TBL] [Abstract][Full Text] [Related]
19. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Zamarron C; Lijnen HR; Van Hoef B; Collen D Thromb Haemost; 1984 Aug; 52(1):19-23. PubMed ID: 6495259 [TBL] [Abstract][Full Text] [Related]
20. Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activator. Lijnen HR; Nelles L; Holmes WE; Collen D J Biol Chem; 1988 Apr; 263(12):5594-8. PubMed ID: 2965704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]